Park Kyong Soo
Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-744, Republic of Korea.
Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S33-5. doi: 10.1016/j.diabres.2003.11.023.
The prevalence of type 2 diabetes mellitus has increased worldwide over the past decades. The economic and social cost associated with diabetes mellitus and its complications have also increased enormously. Since current methods of treating diabetes is inadequate, the most effective way to reduce the burden associated with type 2 diabetes would be to prevent diabetes itself. Current strategies to prevent type 2 diabetes mellitus are based on efforts to reduce insulin resistance and to preserve or increase pancreatic beta cell function in high risk individuals. Now there is substantial evidence that life style intervention or pharmacologic agents can reduce the development of diabetes in individuals with impaired glucose tolerance. However, it remains to be determined whether the result would be similar in other risk groups for type 2 diabetes. Although development of type 2 diabetes mellitus is influenced by a complex interaction between genetic and environmental factors, current prevention strategies do not reflect contribution of genetic factors. Over the past decade, many investigators tried to find diabetogenic genes by traditional gene discovery methods. It appears that multiple genes with weak effect are involved in the development of type 2 diabetes mellitus which makes searching diabetogenic genes more complicated. In addition to the completion of human genome project, new genetic tools to identify genetic variations and analyze gene to gene or gene to environmental interaction will facilitate the discovery of susceptibility genes for type 2 diabetes mellitus in near future. Once we could identify susceptibility genes and gene to environmental interaction of type 2 diabetes mellitus, we can clarify the role of both environmental and genetic factors in the development of type 2 diabetes mellitus. Moreover, we can identify people who can get more benefit from prevention and also can provide better and personalized preventive measure based on genetic information.
在过去几十年里,2型糖尿病的患病率在全球范围内有所上升。与糖尿病及其并发症相关的经济和社会成本也大幅增加。由于目前治疗糖尿病的方法并不充分,减轻2型糖尿病相关负担的最有效方法是预防糖尿病本身。目前预防2型糖尿病的策略基于降低胰岛素抵抗以及在高危个体中维持或增强胰腺β细胞功能的努力。现在有大量证据表明,生活方式干预或药物可以降低糖耐量受损个体患糖尿病的风险。然而,在2型糖尿病的其他风险群体中结果是否相似仍有待确定。尽管2型糖尿病的发生受遗传和环境因素之间复杂相互作用的影响,但目前的预防策略并未反映遗传因素的作用。在过去十年中,许多研究人员试图通过传统的基因发现方法寻找致糖尿病基因。似乎多个作用微弱的基因参与了2型糖尿病的发生,这使得寻找致糖尿病基因更加复杂。除了人类基因组计划的完成,用于识别基因变异以及分析基因与基因或基因与环境相互作用的新基因工具将在不久的将来促进2型糖尿病易感基因的发现。一旦我们能够识别2型糖尿病的易感基因以及基因与环境的相互作用,我们就可以阐明环境和遗传因素在2型糖尿病发生中的作用。此外,我们可以识别出能从预防中获益更多的人群,并根据遗传信息提供更好的个性化预防措施。